Your browser doesn't support javascript.
loading
Long-term results of a phase 2 study of rituximab and bendamustine for mucosa-associated lymphoid tissue lymphoma.
Salar, Antonio; Domingo-Domenech, Eva; Panizo, Carlos; Nicolás, Concepción; Bargay, Joan; Muntañola, Ana; Canales, Miguel; Bello, José Luis; Sancho, Juan Manuel; Tomás, José Francisco; Rodríguez, María José; Peñalver, Javier; Grande, Carlos; Sánchez-Blanco, José Javier; Palomera, Luis; Arranz, Reyes; Conde, Eulogio; García, Mar; García, Juan Fernando; Caballero, Dolores; Montalbán, Carlos.
Afiliação
  • Salar A; Department of Hematology, Hospital del Mar, Barcelona, Spain.
  • Domingo-Domenech E; Department of Hematology, Hospital Durans i Reynals, Barcelona, Spain.
  • Panizo C; Department of Hematology, Clínica Universitaria de Navarra, Pamplona, Spain.
  • Nicolás C; Department of Hematology, Hospital Central de Asturias, Asturias, Spain.
  • Bargay J; Department of Hematology, Hospital Son Llatzer, Mallorca, Spain.
  • Muntañola A; Department of Hematology, Hospital Universitario Mutua de Terrassa, Terrassa, Spain.
  • Canales M; Department of Hematology, Hospital Universitario La Paz, Madrid, Spain.
  • Bello JL; Department of Hematology, Complejo Universitario de Santiago, Santiago de Compostela, Spain.
  • Sancho JM; Department of Hematology, Hospital Germans Trias i Pujol, Badalona, Spain.
  • Tomás JF; Department of Hematology, MD Anderson Cancer Center, Madrid, Spain.
  • Rodríguez MJ; Department of Hematology, Hospital Universitario de Canarias, Tenerife, Spain.
  • Peñalver J; Department of Hematology, Hospital Fundación Alcorcón, Alcorcón, Spain.
  • Grande C; Department of Hematology, Hospital Universitario 12 de Octubre, Madrid, Spain.
  • Sánchez-Blanco JJ; Department of Hematology, Hospital Morales Meseguer, Murcia, Spain.
  • Palomera L; Department of Hematology, Hospital Clínico Lozano Blesa, Zaragoza, Spain.
  • Arranz R; Department of Hematology, Hospital Universitario La Princesa, Madrid, Spain.
  • Conde E; Department of Hematology, Hospital Marqués de Valdecilla, Santander, Spain.
  • García M; Department of Anatomic Pathology, Hospital Universitario Miguel Servet, Zaragoza, Spain.
  • García JF; Department of Anatomic Pathology, MD Anderson Cancer Center, Madrid, Spain; and.
  • Caballero D; Department of Hematology, Hospital Clínico de Salamanca, Salamanca, Spain.
  • Montalbán C; Department of Hematology, MD Anderson Cancer Center, Madrid, Spain.
Blood ; 130(15): 1772-1774, 2017 10 12.
Article em En | MEDLINE | ID: mdl-28801448
Assuntos
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Linfoma de Zona Marginal Tipo Células B / Cloridrato de Bendamustina / Rituximab Tipo de estudo: Clinical_trials / Observational_studies / Prognostic_studies / Risk_factors_studies Limite: Adult / Aged / Aged80 / Female / Humans / Male / Middle aged Idioma: En Revista: Blood Ano de publicação: 2017 Tipo de documento: Article País de afiliação: Espanha
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Linfoma de Zona Marginal Tipo Células B / Cloridrato de Bendamustina / Rituximab Tipo de estudo: Clinical_trials / Observational_studies / Prognostic_studies / Risk_factors_studies Limite: Adult / Aged / Aged80 / Female / Humans / Male / Middle aged Idioma: En Revista: Blood Ano de publicação: 2017 Tipo de documento: Article País de afiliação: Espanha